A phase I study of ridaforolimus (MK-8669) in pediatric patients with advanced solid tumors.
Andrew DJ Pearson
No relevant relationships to disclose
Sara Michele Federico
No relevant relationships to disclose
Isabelle Aerts
No relevant relationships to disclose
Darren R Hargrave
No relevant relationships to disclose
Steven G. DuBois
Research Funding - Merck
Robert Iannone
Employment or Leadership Position - Merck
Stock Ownership - Merck
Other Remuneration - Merck
Ryan Geschwindt
Employment or Leadership Position - Merck Sharp & Dohme
Stock Ownership - Merck
Ruixue Wang
No relevant relationships to disclose
Tanya M. Trippett
No relevant relationships to disclose
Birgit Geoerger
No relevant relationships to disclose